| Year |
Citation |
Score |
| 2019 |
Najt CP, Khan SA, Heden TD, Witthuhn BA, Perez M, Heier JL, Mead LE, Franklin MP, Karanja KK, Graham MJ, Mashek MT, Bernlohr DA, Parker L, Chow LS, Mashek DG. Lipid Droplet-Derived Monounsaturated Fatty Acids Traffic via PLIN5 to Allosterically Activate SIRT1. Molecular Cell. PMID 31901447 DOI: 10.1016/J.Molcel.2019.12.003 |
0.391 |
|
| 2016 |
Zhang W, Bu SY, Mashek MT, O-Sullivan I, Sibai Z, Khan SA, Ilkayeva O, Newgard CB, Mashek DG, Unterman TG. Integrated Regulation of Hepatic Lipid and Glucose Metabolism by Adipose Triacylglycerol Lipase and FoxO Proteins. Cell Reports. PMID 27050511 DOI: 10.1016/J.Celrep.2016.03.021 |
0.506 |
|
| 2015 |
Khan SA, Wollaston-Hayden EE, Markowski TW, Higgins L, Mashek DG. Quantitative analysis of the murine lipid droplet-associated proteome during diet-induced hepatic steatosis. Journal of Lipid Research. PMID 26416795 DOI: 10.1194/Jlr.M056812 |
0.423 |
|
| 2015 |
Mashek DG, Khan SA, Sathyanarayan A, Ploeger JM, Franklin MP. Hepatic lipid droplet biology: Getting to the root of fatty liver. Hepatology (Baltimore, Md.). PMID 25854913 DOI: 10.1002/Hep.27839 |
0.375 |
|
| 2015 |
Khan SA, Sathyanarayan A, Mashek MT, Ong KT, Wollaston-Hayden EE, Mashek DG. ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1α/PPAR-α signaling. Diabetes. 64: 418-26. PMID 25614670 DOI: 10.2337/Db14-0325 |
0.359 |
|
| 2010 |
Mulukutla BC, Khan S, Lange A, Hu WS. Glucose metabolism in mammalian cell culture: new insights for tweaking vintage pathways. Trends in Biotechnology. 28: 476-84. PMID 20691487 DOI: 10.1016/J.Tibtech.2010.06.005 |
0.374 |
|
| 2008 |
Mukhtar MH, Payne VA, Arden C, Harbottle A, Khan S, Lange AJ, Agius L. Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 294: R766-74. PMID 18199594 DOI: 10.1152/Ajpregu.00593.2007 |
0.346 |
|
| 2008 |
Arden C, Hampson LJ, Huang GC, Shaw JA, Aldibbiat A, Holliman G, Manas D, Khan S, Lange AJ, Agius L. A role for PFK-2/FBPase-2, as distinct from fructose 2,6-bisphosphate, in regulation of insulin secretion in pancreatic beta-cells. The Biochemical Journal. 411: 41-51. PMID 18039179 DOI: 10.1042/Bj20070962 |
0.457 |
|
| 2007 |
Wu C, Khan SA, Peng LJ, Li H, Carmella SG, Lange AJ. Erratum: Perturbation of glucose flux in the liver by decreasing fructose-2,6-bisphosphate levels causes hepatic insulin resistance and hyperglycemia (American Journal of Physiology-Endocrinology and Metabolism (2006) 291, 54, (E536-E543)) American Journal of Physiology-Endocrinology and Metabolism. 292. DOI: 10.1152/Ajpendo.Zh1-4813-Corr.2007 |
0.423 |
|
| 2006 |
Wu C, Khan SA, Peng LJ, Lange AJ. Roles for fructose-2,6-bisphosphate in the control of fuel metabolism: beyond its allosteric effects on glycolytic and gluconeogenic enzymes. Advances in Enzyme Regulation. 46: 72-88. PMID 16860376 DOI: 10.1016/J.Advenzreg.2006.01.010 |
0.497 |
|
| 2006 |
Wu C, Khan SA, Peng LJ, Li H, Carmella SG, Lange AJ. Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia. American Journal of Physiology. Endocrinology and Metabolism. 291: E536-43. PMID 16621898 DOI: 10.1152/Ajpendo.00126.2006 |
0.394 |
|
| 2005 |
Wu C, Khan SA, Lange AJ. Regulation of glycolysis-role of insulin. Experimental Gerontology. 40: 894-9. PMID 16157461 DOI: 10.1016/J.Exger.2005.08.002 |
0.365 |
|
| 2005 |
Wu C, Kang JE, Peng LJ, Li H, Khan SA, Hillard CJ, Okar DA, Lange AJ. Enhancing hepatic glycolysis reduces obesity: differential effects on lipogenesis depend on site of glycolytic modulation. Cell Metabolism. 2: 131-40. PMID 16098830 DOI: 10.1016/J.Cmet.2005.07.003 |
0.376 |
|
| Show low-probability matches. |